Verified Nov 2026
Other
·

Sao Paulo, State of Sao Paulo
·
Since 2001
Hypera is a Brazilian pharmaceutical company founded in 2001 and headquartered in São Paulo. With 10,000–50,000 employees and estimated revenue of $1–5 billion, it operates as a private firm serving automotive, electric vehicle, medical, renewable energy, and industrial equipment sectors. The company produces prescription medicines, over-the-counter consumer health products, generics, and dermocosmetics under brands including Benegrip and Buscopan, distributing across Brazil through retailers, wholesalers, and direct sales channels.
Hypera at a glance
Revenue
$1-5B
Est. band
Employees
10,000-50,000
Founded
2001
Headquarters
Sao Paulo, State of Sao Paulo
Industries
Automotive
Electric Vehicles
Medical
Renewable Energy
Industrial Equipment
Overview
Hypera is a Brazilian pharmaceutical company founded in 2001 and headquartered in São Paulo. With 10,000–50,000 employees and estimated revenue of $1–5 billion, it operates as a private firm serving automotive, electric vehicle, medical, renewable energy, and industrial equipment sectors. The company produces prescription medicines, over-the-counter consumer health products, generics, and dermocosmetics under brands including Benegrip and Buscopan, distributing across Brazil through retailers, wholesalers, and direct sales channels.
At a glance
Attribute | Detail |
|---|---|
Founded | 2001 |
Headquarters | Sao Paulo, State of Sao Paulo |
Employees | 10,000-50,000 |
Revenue | $1-5B (estimated) |
What Hypera makes
The company operates one of Brazil's pharmaceutical research centers through its subsidiary Brainfarma and produces prescription medicines, generics, over-the-counter products, dermocosmetics, vitamins, and supplements.
Latest developments
2026-08-07 — Consideramos aquisições somente depois de atingir a meta de desalavancagem, diz Hypera | Empresas | Valor Econômico (globo.com)
2026-08-06 — Farmacêutica Hypera lucra R$ 490 milhões no 2º tri, alta de 15% (uol.com.br)
2026-07-14 — Astellas anuncia parceria estratégica com a Hypera para ampliar o acesso ao fezolinetanto no Brasil e lançar uma nova marca (astellas.com)
2026-06-25 — Hypera registra nova caneta de semaglutida produzida no Brasil (balponte.com.br)
2025-08-28 — Fiocruz e Hypera Pharma vão produzir medicamento para Atrofia Muscular Espinhal | Portal Fiocruz (fiocruz.br)
2025-03-10 — Votorantim amplia para 11% participação na Hypera e quer dialogar sobre 'eventual papel na governança' | Empresas | Valor Econômico (globo.com)
Company details
Hypera reported net profit of 490 million reais in the second quarter of 2026, representing 15 percent growth year-over-year. Hypera was founded in 2001, has an estimated 10,000-50,000 employees, and is headquartered in Sao Paulo, State of Sao Paulo.
Frequently asked questions
What does Hypera do?
Hypera is a Brazilian pharmaceutical company founded in 2001 and headquartered in São Paulo. With 10,000–50,000 employees and estimated revenue of $1–5 billion, it operates as a private firm serving automotive, electric vehicle, medical, renewable energy, and industrial equipment sectors. The company produces prescription medicines, over-the-counter consumer health products, generics, and dermocosmetics under brands including Benegrip and Buscopan, distributing across Brazil through retailers, wholesalers, and direct sales channels.
Where is Hypera headquartered?
Hypera is headquartered in Sao Paulo, State of Sao Paulo (4800 Avenida Magalhaes de Castro, Sao Paulo, State of Sao Paulo, 05502-001).
When was Hypera founded?
Hypera was founded in 2001.
How big is Hypera?
Hypera has an estimated 10,000-50,000 employees, with revenue in the $1-5B range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
